Development of a stress induced validated UPLC-PDA method for the analysis of Eslicarbazepine acetate

Development of a stress induced validated UPLC-PDA method for the analysis of Eslicarbazepine acetate

Bibliographic Details
Main Authors:	Farah Iram, Perwez Alam, Nasir A. Siddiqui, Saleh I. Alqasoumi, Anees A. Siddiqui, Shah Alam Khan, Asif Husain
Format:	Article
Language:	English
Published:	Elsevier 2018-02-01
Series:	Saudi Pharmaceutical Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S1319016417302049

Similar Items

Eslicarbazepine acetate: A therapeutic agent of paramount importance in acute anticonvulsant therapy
by: Farah Iram, et al.
Published: (2017-01-01)

Identification of metabolic pathways involved in the biotransformation of eslicarbazepine acetate using UPLC-MS/MS, human microsomal enzymes and in silico studies
by: Asif Husain, et al.
Published: (2021-03-01)

Interspecies Anticancer and Antimicrobial Activities of Genus Solanum and Estimation of Rutin by Validated UPLC-PDA Method
by: Mohamed Fahad Alajmi, et al.
Published: (2018-01-01)

Development and validation of UPLC-PDA method for concurrent analysis of bergenin and menisdaurin in aerial parts of Flueggea virosa (Roxb. ex Willd.)
by: Afzal Hussain, et al.
Published: (2018-11-01)

Eslicarbazepine acetate for trigeminal neuralgia
by: A. Sanchez-Larsen, et al.
Published: (2020-11-01)

Update on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsy
by: Tambucci R, et al.
Published: (2016-05-01)

Dibenzazepine Agents in Epilepsy: How Does Eslicarbazepine Acetate Differ?
by: Charlotte Lawthom, et al.
Published: (2018-09-01)

Eslicarbazepine Acetate Modulates EEG Activity and Connectivity in Focal Epilepsy
by: Giovanni Pellegrino, et al.
Published: (2018-12-01)

Eslicarbazepine acetate for neuropathic pain, headache, and cranial neuralgia: evidence and experience
by: A. Alcántara Montero, et al.
Published: (2019-07-01)

EPICON consensus: Recommendations for proper management of switching to eslicarbazepine acetate in epilepsy
by: V. Villanueva, et al.
Published: (2018-06-01)

Inhibitory Effect of Eslicarbazepine Acetate and S-Licarbazepine on Nav1.5 Channels
by: Theresa K. Leslie, et al.
Published: (2020-10-01)

A Review of Eslicarbazepine Acetate for the Adjunctive Treatment of Partial-Onset Epilepsy
by: Rajinder P. Singh, et al.
Published: (2011-01-01)

Establishment of inherent stability on piracetam by UPLC/HPLC and development of a validated stability-indicating method
by: Kapendra Sahu, et al.
Published: (2017-02-01)

A review of the efficacy and safety of eslicarbazepine acetate in the management of partial-onset seizures
by: Rodrigo Rocamora
Published: (2015-07-01)

Phytochemistry and potential therapeutic actions of Boswellic acids: A mini-review
by: Farah Iram, et al.
Published: (2017-06-01)

A comprehensive review on Brigatinib – A wonder drug for targeted cancer therapy in non-small cell lung cancer
by: Silky Bedi, et al.
Published: (2018-09-01)

Clinical utility of eslicarbazepine: current evidence
by: Zaccara G, et al.
Published: (2015-02-01)

Comments on the Eslicarbazepine Acetate Section of the Article ‘Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications’
by: Patricio Soares-da-Silva, et al.
Published: (2010-12-01)

Response surface methodology-based optimization of ultrasound-assisted extraction of β-sitosterol and lupeol from astragalus atropilosus (roots) and validation by HPTLC method
by: Perwez Alam, et al.
Published: (2020-01-01)

Comparative anticancer and antimicrobial activity of aerial parts of Acacia salicina, Acacia laeta, Acacia hamulosa and Acacia tortilis grown in Saudi Arabia
by: Mohamed F. Alajmi, et al.
Published: (2017-12-01)

Development and Validation of a Versatile UPLC-PDA Method for Simultaneous Determination of Paracetamol, Tizanidine, Aceclofenac, and Nimesulide in Their New Combinations
by: Sami Bawazeer, et al.
Published: (2018-01-01)

Synthesis, reactions and biological activity of 3-arylidene-5-(4-methylphenyl)-2(3H)-furanones
by: ASIF HUSAIN, et al.
Published: (2009-02-01)

A review on dronedarone: Pharmacological, pharmacodynamic and pharmacokinetic profile
by: Farah Iram, et al.
Published: (2016-03-01)

Update on treatment of partial onset epilepsy: role of eslicarbazepine
by: Markus Rauchenzauner, et al.
Published: (2010-11-01)

Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy
by: Sunkaraneni S, et al.
Published: (2017-06-01)

Impact of Early Initiation of Eslicarbazepine Acetate on Economic Outcomes Among Patients with Focal Seizure: Results from Retrospective Database Analyses
by: Darshan Mehta, et al.
Published: (2020-09-01)

Comparative Economic Outcomes in Patients with Focal Seizure Initiating First-Line Eslicarbazepine Acetate Monotherapy versus Generic Antiseizure Drugs
by: Mehta D, et al.
Published: (2021-04-01)

Anticancer activity and concurrent analysis of ursolic acid, β-sitosterol and lupeol in three different Hibiscus species (aerial parts) by validated HPTLC method
by: Perwez Alam, et al.
Published: (2018-11-01)

Comparative study of antioxidant activity and validated RP-HPTLC analysis of rutin in the leaves of different Acacia species grown in Saudi Arabia
by: Perwez Alam, et al.
Published: (2017-07-01)

Synthesis, reactions and biological activity of 3-arylidene-5-(4-methylphenyl)-2(3H)-furanones?
by: Husain Asif, et al.
Published: (2009-01-01)

UPLC–PDA‐ESI–QTOF–MS/MS and GC‐MS analysis of Iranian Dracocephalum moldavica L.
by: Azin Fattahi, et al.
Published: (2021-08-01)

Qualitative and quantitative analysis data of the major constituents of Ilex paraguariensis leaves by UPLC-PDA and QTOF-MS
by: Carlos Henrique Blum-Silva, et al.
Published: (2016-09-01)

Nutrition assessment of vitamin A and vitamin D in northeast Chinese population based-on SPE/UPLC/PDA
by: Maoqing Wang, et al.
Published: (2018-03-01)

Post-authorisation study of eslicarbazepine as treatment for drug-resistant epilepsy: preliminary results
by: A. Massot, et al.
Published: (2014-03-01)

Healthcare Resource Utilization Pre- and Post-Initiation of Eslicarbazepine Acetate Among Pediatric Patients with Focal Seizure: Evidence from Routine Clinical Practice
by: Mehta D, et al.
Published: (2020-07-01)

Effectiveness and Safety/Tolerability of Eslicarbazepine Acetate in Epilepsy Patients Aged ≥ 60 Versus < 60 Years: A Subanalysis from the Euro-Esli Study
by: Charlotte Lawthom, et al.
Published: (2019-05-01)

Rapid, Validated UPLC-MS/MS Method for Determination of Glibenclamide in Rat Plasma
by: Mohd Aftab Alam, et al.
Published: (2018-01-01)

Eslicarbazepine Induced Stevens-Johnson Syndrome: A Rare Case Report
by: Kamal Nath, et al.
Published: (2018-06-01)

Role of eslicarbazepine in the treatment of epilepsy in adult patients with partial-onset seizures
by: Martin E Brown, et al.
Published: (2010-03-01)

Impact of Cluster Zone Leaf Removal on Grapes cv. Regent Polyphenol Content by the UPLC-PDA/MS Method
by: Kamila Mijowska, et al.
Published: (2016-12-01)